Tag Archives: Medicine

SANUWAVE’S PACE Shows Promise In Stimulating Autogenous Sources Of Progenitor/STEM Cells For Harvest And Re-Transplantation In Bone Tissue Engineering

SANUWAVE Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reported that scientific findings titled “Extracorporeal Shock Wave Stimulation of Osteoprogenitor Cells” were presented at the 2009 International Bone-Tissue-Engineering Congress (“Bone-Tec”) in Hannover, Germany, which was held October 9-11, 2009.

Dr. Myron Spector, PhD, Professor of Orthopaedic Surgery (Biomaterials) at Harvard Medical School, Director of Orthopaedic Research at Brigham and Women’s Hospital and Director of Tissue Engineering at VA Boston Healthcare System, was an invited guest speaker at the Conference. The
Read More…

GREAT BRITAIN – Stem cells used to repair Achilles tendon. Human testing to take place soon.

Image via Wikipedia

It works in racehorses. Who knows if it’s possible in humans. A technique using stem cells to repair damage to the Achilles tendon is about to be tested in Great Britain.

British biotech company MedCell Bioscience has announced that it will begin human testing in the next six months and expects to perform a broad study in various European hospitals in 2011.

Patients will receive injections containing millions of their own stem cells extracted and multiplied in the lab to regenerate damaged tissue. Over 1,500 racehorses have been treated with the same procedure and the results
Read More…

China and California collaboration on Stem Cells

The California Institute for Regenerative Medicine (CIRM) and the Chinese Ministry of Science and Technology (MOST) have agreed to collaborate on stem cell research. The agreement will make it easier to form cross-border teams that are working in similar areas. If the teams’ funding requests are approved, the researchers in each country will be supported by their respective agency, CIRM or MOST. The formal announcement, made today, adds details to a story that ChinaBio® Today originally broke late last week (…)

“Our collaboration will benefit patients in our countries and patients around the globe,” said Wan Gang, Minister, MOST. “We
Read More…

Stanford’s Irving Weissman on the (lost?) promise of stem cells

Stanford stem cell researcher Irving Weissman, MD, published an article in Cell Stem Cell today discussing barriers to stem cell research:

While I am usually an optimist, I must admit that there is a possibility that we will continue to be in the Dark Ages of medicine for quite some time. I fear that therapies using purified tissue and organ-specific stem cells – the only self-renewing cells in a tissue or that can regenerate that tissue or organ for life – will remain elusive.

Weissman, who directs Stanford’s Institute for Stem Cell Biology and Regenerative Medicine, goes on to cover the
Read More…

Promoting Healing by Keeping Skeletal Stem Cells ‘Young’

Image via Wikipedia

Scientists seeking new ways to fight maladies ranging from arthritis and osteoporosis to broken bones that won’t heal have cleared a formidable hurdle, pinpointing and controlling a key molecular player to keep stem cells in a sort of extended infancy. It’s a step that makes treatment with the cells in the future more likely for patients.

Controlling and delaying development of the cells, known as mesenchymal (pronounced meh-ZINK-a-mill) stem cells, is a long-sought goal for researchers. It’s a necessary step for doctors who would like to expand the number of true
Read More…